| Patents for C07C 401 - Irradiation products of cholesterol or its derivatives; Vitamin d derivatives, 9,10-seco cyclopenta[a]phenanthrene or analogues obtained by chemical preparation without irradiation (3,426) |
|---|
| 01/14/2010 | WO2010006172A2 2-methylene-20(21)-dehydro-19-nor-vitamin d analogs |
| 01/14/2010 | WO2010006169A2 2-methylene-19, 26-dinor-(20s, 22e, 25r)-vitamin d analogs |
| 01/14/2010 | WO2010006162A2 2-methylene-(20e)-20(22)-dehydro-19-nor-vitamin d analogs |
| 01/14/2010 | WO2010006135A2 2-methylene-(17z)-17(20)-dehydro-19,21-dinor-vitamin d analogs |
| 01/14/2010 | WO2010006129A2 2-methylene-(22e)-25-(1-methylene-hexyl)-26,27-cyclo-22-dehydro-19-nor-vitamin d analogs |
| 01/14/2010 | WO2010006125A2 2-methylene-19,26-dinor-(20r,22e,25r)-vitamin d analogs |
| 01/14/2010 | US20100009947 2-Methylene-19,26-Dinor-(20S,22E,25R)-Vitamin D Analogs |
| 01/14/2010 | US20100009946 2-Methylene-19,26-Dinor-(20R,22E,25R)-Vitamin D Analogs |
| 01/14/2010 | US20100009943 2-Methylene-(22E)-25-(1-Methylene-Hexyl)-26,27-Cyclo-22-Dehydro-19-Nor-Vitamin D Analogs |
| 01/14/2010 | US20100009942 2-Methylene-(17Z)-17(20)-Dehydro-19,21-Dinor-Vitamin D Analogs |
| 01/14/2010 | US20100009941 2-Methylene-20(21)-Dehydro-19-Nor-Vitamin D Analogs |
| 01/14/2010 | US20100009940 2-Methylene-(20E)-20(22)-Dehydro-19-Nor-Vitamin D Analogs |
| 01/14/2010 | CA2730257A1 2-methylene-19,26-dinor-(20s,22e,25r)-vitamin d analogs |
| 01/14/2010 | CA2730254A1 2-methylene-(17z)-17(20)-dehydro-19,21-dinor-vitamin d analogs |
| 01/14/2010 | CA2730248A1 2-methylene-(20e)-20(22)-dehydro-19-nor-vitamin d analogs |
| 01/14/2010 | CA2730247A1 2-methylene-20(21)-dehydro-19-nor-vitamin d analogs |
| 01/14/2010 | CA2730244A1 2-methylene-19,26-dinor-(20r,22e,25r)-vitamin d analogs |
| 12/30/2009 | WO2009117831A9 Hybrid molecules having mixed vitamin d receptor agonism and histone deacetylase inhibitory properties |
| 12/24/2009 | US20090318722 Process for preparation of paricalcitol intermediates |
| 12/24/2009 | DE102008061497A1 Verfahren zur Herstellung von Paricalcitol und Zwischenprodukten davon Process for the preparation of paricalcitol and intermediates thereof |
| 12/23/2009 | CN101607932A Method and device for preparing calcitriol by utilizing photochemical reaction |
| 12/23/2009 | CN101607931A Preparation method of calcitriol |
| 12/09/2009 | EP1981843B1 Vitamin d analog: nel, methods and uses thereof |
| 12/08/2009 | CA2404725C Extrusion die |
| 12/03/2009 | US20090298800 1,25-dihydroxy, 20-cyclopropyl,26-27-deuteroalkyl vitamin d3 compounds and methods of use thereof |
| 11/26/2009 | WO2009067578A3 New vitamin d receptor activators and methods of making |
| 11/25/2009 | CN101589023A Process for production of 1-hydroxy-19-norcyclovitamin D derivative and intermediate for the production |
| 11/12/2009 | US20090281340 1alpha-hydroxy-2-(3'-hydroxypropylidene)-19-nor-vitamin d compounds and methods of making and treatment thereof |
| 11/05/2009 | US20090275768 Preparation of Paricalcitol |
| 10/06/2009 | CA2416194C Use of 2-methylene-19-nor-20(s)-1.alpha.,25-dihydroxyvitamin d3 to increase bone strength |
| 10/01/2009 | WO2009117831A1 Hybrid molecules having mixed vitamin d receptor agonism and histone deacetylase inhibitory properties |
| 09/29/2009 | CA2489593C Epimerization of analogs of vitamin d |
| 09/29/2009 | CA2403232C 26,27-homologated-20-epi-2-alkyl-19-nor-vitamin d compounds |
| 09/29/2009 | CA2306573C Process for preparing antiosteoporotic agents |
| 09/17/2009 | WO2009111873A1 Stabilized 1,25-dihydroxyvitamin d2 and method of making same |
| 09/17/2009 | US20090233889 Stabilized 1,25-dihydroxyvitamin d2 and method of making same |
| 09/17/2009 | CA2718238A1 Stabilized 1,25-dihydroxyvitamin d2 and method of making same |
| 09/11/2009 | WO2007038428A3 Prevention and treatment of gastrointestinal and bladder disorders using active vitamin d compounds |
| 09/08/2009 | CA2468833C (20s)-1.alpha.-hydroxy-2-methylene-19-nor-bishomopregnacalciferol and its uses |
| 09/02/2009 | CN100534981C 2-propylidene-19-nor-vitamin d compounds |
| 08/27/2009 | WO2009086439A3 2-methylene-(20s,25s)-19,26-dinor-vitamin d analogs |
| 08/19/2009 | CN101508666A Method for photocatalysis preparation of tachysterol |
| 08/18/2009 | US7575767 Extraction of palm vitamin E, phytosterols and squalene from palm oil |
| 08/05/2009 | EP2085380A1 Process for production of 1-hydroxy-19-norcyclovitamin d derivative and intermediate for the production |
| 07/30/2009 | WO2009094426A1 13,13-dimethyl-des-c,d analogs of 1alpha, 25-dihydroxy-19-nor-vitamin d3 compounds and topical composition dosage forms and methods of treating skin conditions thereof |
| 07/30/2009 | CA2712748A1 13,13-dimethyl-des-c,d analogs of 1.alpha.,25-dihydroxy-19-nor-vitamin d3 compounds and topical composition dosage forms and methods of treating skin conditions thereof |
| 07/23/2009 | WO2008125901A8 2-methylene-1alpha,25-dihydroxy-18,19,21-trinorvitamin d3 and uses thereof |
| 07/21/2009 | US7563783 High binding to vitamin D receptors; intestinal calcium transport activity; psoriasis; leukemia; anticarcinogenic agents; multiple sclerosis; lupus; antidiabetic agents; host versus graft/organ reaction; antiinflammatory agents; rheumatoid arthritis; asthma; inflammatory bowel disease; skin/bone disorder |
| 07/21/2009 | CA2404548C 2-alkylidene-19-nor-vitamin d compounds and their therapeutic uses |
| 07/09/2009 | WO2009086440A1 2-methylene-20-methyl-19,24,25,26,27-pentanor-vitamin d analogs |
| 07/09/2009 | WO2009086439A2 2-methylene-(20s,25s)-19,26-dinor-vitamin d analogs |
| 07/09/2009 | WO2009086437A1 (20r)-23,23-difluoro-2-methylene-19-nor-bishomopregnacalciferol-vitamin d analogs |
| 07/09/2009 | WO2009086436A1 (20s)-23,23-difluoro-2-methylene-19-nor-bishomopregnacalciferol-vitamin d analogs |
| 07/09/2009 | US20090177002 Method For Preparing Indene Derivatives, And Intermediates For Preparation Of Derivatives |
| 07/09/2009 | CA2710977A1 2-methylene-20-methyl-19,24,25,26,27-pentanor-vitamin d analogs |
| 07/09/2009 | CA2710974A1 2-methylene-(20s,25s)-19,26-dinor-vitamin d analogs |
| 07/09/2009 | CA2710966A1 (20r)-23,23-difluoro-2-methylene-19-nor-bishomopregnacalciferol-vitamin d analogs |
| 07/09/2009 | CA2710954A1 (20s)-23,23-difluoro-2-methylene-19-nor-bishomopregnacalciferol-vitamin d analogs |
| 07/02/2009 | US20090170822 2-Methylene-20-Methyl-19,24,25,26,27-Pentanor-Vitamin D Analogs |
| 07/02/2009 | US20090170821 2-Methylene-(20S,25S)-19,26-Dinor-Vitamin D Analogs |
| 07/02/2009 | US20090170820 2-Methylene-(20S,25R)-19,26-Dinor-Vitamin D Analogs |
| 07/02/2009 | US20090170819 (20R)-23,23-Difluoro-2-Methylene-19-Nor-Bishomopregnacalciferol-Vitamin D Analogs |
| 07/02/2009 | US20090170818 Arresting the proliferation of undifferentiated cells and inducing their differentiation; anticancer agents; treating psoriasis, wrinkles, slack skin, dry skin, insufficient sebum secretion, autoimmune disorders, inflammatory diseases, renal osteodystrophy. and obesity; little, if any, calcemic activity |
| 06/24/2009 | CN101462994A Vitamin D derivatives |
| 06/17/2009 | EP2070911A2 Stabilized 1Alpha-Hydroxy vitamin D |
| 06/17/2009 | EP2069297A1 2-methylene-(20r,25s)-19,27-dinor-(22e)-vitamin d analogs |
| 06/17/2009 | EP2069296A2 2-methylene-(20s,25s)-19,27-dinor-(22e)-vitamin d analogs |
| 06/17/2009 | CN101460455A 9,10-secopregnane derivative and pharmaceutical |
| 06/04/2009 | WO2008089093A3 Efficient processes for preparing steroids and vitamin d derivatives with the unnatural configuration at c20 (20 alpha-methyl) from pregnenolone |
| 06/04/2009 | US20090143342 26,27-homologated-20-EPI-2-alkylidene-19-nor-vitamin D compounds |
| 06/02/2009 | US7541349 2-methylene-19-nor-(23S)-25-dehydro-1α-hydroxyvitamin D3-26,23-lactone and 2-methylene-19-nor-(23R)-25-dehydro-1α-hydroxyvitamin D3-26,23-lactone |
| 06/02/2009 | US7541348 vitamin d derivatives containing protected hydroxy groups; useful for treating leukemia; colon, breast and prostatae cancer; multiple sclerosis; lupus; diabetes mellitus; host versus graft reaction, rheumatoid arthritis, asthma, or inflammatory bowel diseases; and a skin condition |
| 05/28/2009 | WO2009067578A2 New vitamin d receptor activators and methods of making |
| 05/28/2009 | US20090137828 Synthesis of 1A-Fluoro-25-Hydroxy-16-23E-Diene-26,27-Bishomo-20-Epi-Cholecalciferol |
| 05/28/2009 | US20090137536 Method for treating and preventing hyperparathyroidism |
| 05/28/2009 | CA2705987A1 New vitamin d receptor activators and methods of making |
| 05/21/2009 | US20090131379 Vitamin d receptor activators and methods of making |
| 05/14/2009 | US20090124819 2-substituted vitamin d derivatives |
| 05/12/2009 | US7531527 (20R)-1 alpha ,25-dihydroxy-2-[3'-hydroxypropylidene]-19-norvitamin D3; high intestinal calcium transport activity; ability to mobilize calcium from bone; bone replacement surgeries, autoimmune diseases, multiple sclerosis, diabetes mellitus,lupus, antiproliferative agents |
| 05/06/2009 | EP2054540A2 Tagging reagents and methods for hydroxylated compounds |
| 05/05/2009 | US7528122 2-Methylene-19,26-dinor-1 alpha ,25-dihydroxyvitamin D3; psoriasis; leukemia, cancer, multiple sclerosis; lupus; diabetes mellitus; host versus graft reaction; rejection of organ transplants; decrease the calcemic effect while retaining the ability to suppress parathyroid hormone |
| 04/28/2009 | US7524980 Vitamin D3 lactam derivative |
| 04/21/2009 | CA2259339C Crystals of vitamin d derivatives and process for the preparation thereof |
| 04/16/2009 | US20090099141 Compositions and methods for treating vitamin d deficiencies |
| 04/16/2009 | US20090099140 20-Alkyl, Gemini Vitamin D3 Compounds and Methods of Use Thereof |
| 04/16/2009 | DE202008016372U1 Vitamin enthaltende Zusammensetzung Vitamin-containing composition |
| 04/15/2009 | EP2046737A2 2-methylene-1 alpha,25-dihydroxy-19,21-dinorvitamin d3 analogs and uses thereof |
| 04/15/2009 | EP1419143B1 24-sulfur-substituted analogs of 1alpha,25-dihydroxy vitamin d3 |
| 04/01/2009 | CN101400649A Isomerisation of pharmaceutical intermediates |
| 03/31/2009 | US7511030 vitamin D receptors binder; intestinal calcium transport activity; osteoporosis or renal osteodystrophy; autoimmune diseases: multiple sclerosis, lupus, diabetes mellitus, host versus graft reaction; antiinflammatory: rheumatoid arthritis, asthma, celiac disease, ulcerative colitis and Crohn's disease |
| 03/26/2009 | US20090082317 Low-calcemic 16,23-diene 25-oxime analogs of 1alpha,25-dihydroxy vitamin d3 |
| 03/19/2009 | US20090075953 Deuterium-enriched ed-71 |
| 03/18/2009 | CN100469764C Vitamin D derivatives |
| 03/11/2009 | EP2033965A2 17-alpha-substituted-11-beta-substituted-4-aryl and 21-substituted 19-norpregnadienedione as antiprogestational agents |
| 03/11/2009 | CN101381336A Vitamin D3 preparation method and device |
| 03/03/2009 | CA2410880C 2-ethyl and 2-ethylidene-19-nor-vitamin d compounds |
| 02/26/2009 | WO2009008754A3 Process for the preparation of calcipotriol |
| 02/19/2009 | WO2009022041A1 Ointment for controlling and treating skin diseases and preparation method therefor |
| 02/18/2009 | EP2025667A1 9,10-secopregnane derivative and pharmaceutical |
| 02/17/2009 | US7491711 Methods of treatment using 3-desoxy vitamin D3 analogs |